Clinical Trials
24 trialsNCT03432741 2025-05-26
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Mayo Clinic
Phase 1 Terminated
NCT02810873 2025-05-04
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Thomas Jefferson University
Phase NA Terminated
NCT02317783 2024-11-20
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
University of Utah
Phase 2 Terminated
NCT01246869 2024-10-01
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
University of Utah
Phase 1 Terminated
NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
NCT01931709 2023-11-18
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
Phase NA Terminated
NCT00794339 2023-08-14
ACRIN6682
American College of Radiology
Phase 2 Terminated
NCT01992861 2023-06-26
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
University of Washington
Terminated
NCT03129776 2022-09-22
Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer
Sunnybrook Health Sciences Centre
Phase 1 Terminated
NCT00707213 2022-04-27
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
University of Utah
Phase 1 Terminated
NCT02149173 2021-06-30
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
University of Washington
Phase NA Terminated
NCT00978874 2021-06-25
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT02891616 2019-07-17
18F-FLT PET Imaging in Patients With Advanced Melanoma
Washington University School of Medicine
Phase 1 Terminated
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT00852644 2018-05-11
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase NA Terminated
NCT01222416 2017-07-02
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT02429804 2017-05-30
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Stanford University
Phase 1 Terminated
NCT01494012 2017-04-28
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
Stanford University
Phase 1 Terminated
NCT02112162 2016-12-08
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery
Washington University School of Medicine
Phase 1 Terminated
NCT01283178 2016-10-31
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Virginia Commonwealth University
Phase 1 Terminated
NCT00060008 2014-04-04
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia
Phase NA Terminated
NCT00368329 2012-07-16
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Stanford University
Phase 1 Terminated
NCT00253461 2012-03-20
11C Topotecan PET Imaging
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT00522639 2009-06-30
FDG-PET lung
Maastricht Radiation Oncology
Phase 3 Terminated